David H. Willse

Array ( [id] => 7317494 [patent_doc_number] => 20040224312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Gene causative of rothmund-thomson syndrome and gene product' [patent_app_type] => new [patent_app_number] => 09/889325 [patent_app_country] => US [patent_app_date] => 2001-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15368 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224312.pdf [firstpage_image] =>[orig_patent_app_number] => 09889325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1170432 [patent_doc_number] => 06749853 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Combined methods and compositions for coagulation and tumor treatment' [patent_app_type] => B1 [patent_app_number] => 09/483679 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 55166 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/749/06749853.pdf [firstpage_image] =>[orig_patent_app_number] => 09483679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1270635 [patent_doc_number] => 06653282 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Peptide Compositions which induce immune tolerance and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/479378 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 7025 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653282.pdf [firstpage_image] =>[orig_patent_app_number] => 09479378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443236 [patent_doc_number] => 07256252 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-14 [patent_title] => 'Methods for detecting cell apoptosis' [patent_app_type] => utility [patent_app_number] => 09/473619 [patent_app_country] => US [patent_app_date] => 1999-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7137 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256252.pdf [firstpage_image] =>[orig_patent_app_number] => 09473619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695730 [patent_doc_number] => 07071294 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-04 [patent_title] => 'Tumor antigen protein art-1 and tumor antigen peptide thereof' [patent_app_type] => utility [patent_app_number] => 09/857308 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14831 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071294.pdf [firstpage_image] =>[orig_patent_app_number] => 09857308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 509571 [patent_doc_number] => 07199097 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-04-03 [patent_title] => 'Peptide fragments having cell death inhibitory activity' [patent_app_type] => utility [patent_app_number] => 09/856199 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12180 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/199/07199097.pdf [firstpage_image] =>[orig_patent_app_number] => 09856199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1012583 [patent_doc_number] => 06897054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-24 [patent_title] => 'Human H37 proteins and cDNA encoding the same' [patent_app_type] => utility [patent_app_number] => 09/830647 [patent_app_country] => US [patent_app_date] => 1999-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 6718 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897054.pdf [firstpage_image] =>[orig_patent_app_number] => 09830647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112134 [patent_doc_number] => 07713704 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-05-11 [patent_title] => 'MN gene and protein' [patent_app_type] => utility [patent_app_number] => 09/807949 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 25056 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 367 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713704.pdf [firstpage_image] =>[orig_patent_app_number] => 09807949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073423 [patent_doc_number] => 06838086 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-04 [patent_title] => 'Composition comprising low molecular weight hyaluronic acid fragments' [patent_app_type] => utility [patent_app_number] => 09/763794 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7650 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838086.pdf [firstpage_image] =>[orig_patent_app_number] => 09763794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741942 [patent_doc_number] => 07030212 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'Tumor antigen based on products of the tumor suppressor gene WT1' [patent_app_type] => utility [patent_app_number] => 09/744815 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 4932 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030212.pdf [firstpage_image] =>[orig_patent_app_number] => 09744815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033329 [patent_doc_number] => 20020019332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'METHOD OF INDUCING APOPTOSIS IN B-LYMPHOCYTES' [patent_app_type] => new [patent_app_number] => 09/347334 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4078 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019332.pdf [firstpage_image] =>[orig_patent_app_number] => 09347334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 551718 [patent_doc_number] => 07160679 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-09 [patent_title] => 'Method of diagnosing, monitoring, and staging lung cancer' [patent_app_type] => utility [patent_app_number] => 09/700770 [patent_app_country] => US [patent_app_date] => 1999-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7074 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160679.pdf [firstpage_image] =>[orig_patent_app_number] => 09700770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 442046 [patent_doc_number] => 07255854 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-14 [patent_title] => 'Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases' [patent_app_type] => utility [patent_app_number] => 09/299139 [patent_app_country] => US [patent_app_date] => 1999-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18204 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/255/07255854.pdf [firstpage_image] =>[orig_patent_app_number] => 09299139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056578 [patent_doc_number] => 06855802 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => 'Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy' [patent_app_type] => utility [patent_app_number] => 09/673795 [patent_app_country] => US [patent_app_date] => 1999-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10804 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855802.pdf [firstpage_image] =>[orig_patent_app_number] => 09673795 [rel_patent_id] =>[rel_patent_doc_number] =>)